108 Participants Needed

Contingency Management for Tobacco Use Disorder

(CM_TUD_Cancer Trial)

EH
MM
Overseen ByMadeline Martinez Rivas, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: VA Office of Research and Development
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a program called Contingency Management to help Veterans quit smoking, particularly those undergoing lung cancer screening or cancer care at VA clinics. Contingency Management uses rewards to motivate smoking cessation, and the study will evaluate its effectiveness when combined with counseling and medication via a mobile app. The trial suits Veterans who have smoked recently and are receiving cancer care at the San Francisco VA Healthcare System. As an unphased trial, it provides Veterans with a unique opportunity to explore innovative smoking cessation methods tailored to their needs.

Do I need to stop my current medications to join the trial?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.

What prior data suggests that this Contingency Management protocol is safe for Veterans?

Research has shown that Contingency Management (CM), which uses rewards to help people quit smoking, is generally well-received by participants. Studies have found that CM can reduce smoking during the treatment period. Participants in these studies did not report any major negative effects or side effects from the CM approach itself.

CM relies on positive reinforcement, providing rewards for reaching goals like not smoking. As a behavioral treatment, it does not involve taking drugs or medications specifically for CM, reducing the risk of medical side effects.

Overall, CM is considered a safe method to help people quit smoking, as it primarily relies on motivation and encouragement.12345

Why are researchers excited about this trial?

Researchers are excited about the Contingency Management (CM) approach for Tobacco Use Disorder because it offers a fresh, tech-savvy angle on quitting smoking. Unlike traditional methods such as nicotine replacement therapy or behavioral counseling alone, this approach integrates a mobile-based system that rewards participants for meeting specific goals related to tobacco cessation. By combining this with behavioral counseling and cessation medications, CM aims to make quitting not only more engaging but also more effective. This innovative method could potentially boost motivation and success rates, particularly among veterans receiving cancer care, who might need additional support to quit smoking.

What evidence suggests that Contingency Management is effective for Tobacco Use Disorder?

Research has shown that Contingency Management (CM), which participants in this trial may receive, can help people quit smoking by using rewards. Studies have found that incentives, such as prizes or money, lead to a significant reduction in smoking during treatment. This approach works because people are more likely to change their habits when they receive a clear and immediate reward. This method has also succeeded in treating other substance use issues, providing strong evidence of its effectiveness. Overall, CM is a promising way to help Veterans quit smoking, especially when combined with counseling and medications.13678

Who Is on the Research Team?

EH

Ellen Herbst, MD

Principal Investigator

San Francisco VA Medical Center, San Francisco, CA

Are You a Good Fit for This Trial?

This trial is for US Veterans who are either undergoing lung cancer screening or receiving cancer care at VA clinics and want to quit smoking. They must be willing to participate in focus groups, use a mobile program, and undergo biological testing to verify smoking cessation.

Inclusion Criteria

Have participated in the care of at least 5 VA cancer or LCS patients in the past 6 months
Veteran eligible for VA healthcare
English-speaking
See 9 more

Exclusion Criteria

Veterans: Assessed by Co-PIs' medical record review: Current severe, untreated mental illness (i.e., psychosis, bipolar disorder, and/or substance use disorder (SUD)) and/or Current (past 30 days) active suicidal/homicidal ideation or severe behavioral instability that would prevent participation
Untreated, current, active problem gambling, assessed by medical record diagnosis and/ or Problem Gambling Severity Index (PGSI) score 8
My cancer has spread, or I am receiving end-of-life care.
See 7 more

Timeline for a Trial Participant

Focus Group Development

Development of a mobile CM protocol using qualitative feedback from Veterans and healthcare staff through focus groups.

1 year

Pilot Study

Pilot study to test the feasibility of the mobile CM program along with counseling and medication for 20 Veterans.

5 weeks
Weekly visits (in-person or virtual)

Randomized Controlled Trial (RCT)

RCT to assess the efficacy of mobile CM compared with treatment as usual among Veterans diagnosed with cancer or in lung cancer screening.

3 years
Visits at Weeks 0, 5, 12, 24

Follow-up

Participants are monitored for safety and effectiveness after treatment.

24 weeks
Follow-up visits at Weeks 5, 12, 24

What Are the Treatments Tested in This Trial?

Interventions

  • Contingency Management
Trial Overview The study tests Contingency Management (CM), which rewards Veterans for quitting smoking, verified by tests. It includes developing a mobile CM protocol with Veteran/staff input, then piloting it alongside counseling and medication over five weeks to assess feasibility.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Focus GroupExperimental Treatment1 Intervention
Group II: Contingency ManagementExperimental Treatment2 Interventions
Group III: TUD Treatment as UsualActive Control2 Interventions

Contingency Management is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Contingency Management for:
🇪🇺
Approved in European Union as Contingency Management for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

VA Office of Research and Development

Lead Sponsor

Trials
1,691
Recruited
3,759,000+

University of California, San Francisco

Collaborator

Trials
2,636
Recruited
19,080,000+

Published Research Related to This Trial

In a study involving 142 outpatients with cocaine or heroin dependence, both voucher and prize-based contingency management (CM) interventions led to longer treatment retention and greater durations of confirmed abstinence compared to standard treatment.
While there were no significant differences in abstinence rates at 6- and 9-month follow-ups, the duration of abstinence achieved during treatment was the strongest predictor of continued abstinence after treatment ended.
Vouchers versus prizes: contingency management treatment of substance abusers in community settings.Petry, NM., Alessi, SM., Marx, J., et al.[2016]
In a study involving 81 nicotine-dependent smokers, the addition of prize-based contingency management (CM) to standard care significantly reduced smoking during treatment compared to standard care alone.
However, these reductions in smoking did not persist after the treatment ended, indicating that while prize CM can be effective in the short term, it may not lead to long-term cessation.
Prize contingency management for smoking cessation: a randomized trial.Ledgerwood, DM., Arfken, CL., Petry, NM., et al.[2022]
A survey of 214 substance use treatment providers revealed that while many clinics are using reward programs, they often do not follow effective practices recommended by research, such as providing higher reward amounts or immediate reinforcement.
Providers with more extensive training in contingency management (CM) were more likely to implement effective strategies, suggesting that better training could improve the quality of reward-based interventions in real-world settings.
Examining implementation of contingency management in real-world settings.Rash, CJ., Alessi, SM., Zajac, K.[2021]

Citations

Prize Contingency Management for Smoking CessationOur findings reveal that prize CM leads to significant reductions in smoking during treatment relative to a control intervention, but the benefits did not ...
Incentives for smoking cessation - Notley, C - 2025A randomized trial of contingency management for smoking cessation in the ... Reward-based incentives for smoking cessation: how a carrot became a stick.
Reward-Based Incentives for Smoking Cessation How a ...Other studies have found peer and family support and the use of NRT to be predictors of smoking cessation [3,[29][30][31] [32] . Incentives for participation ...
Financial Incentives for Substance Abstinence: A Systematic ...Financial incentives are likely to be effective for substance use cessation. The evidence for this outcome is highly certain due to the homogeneity of study ...
Voucher-based contingency management and in-treatment ...The present study assessed the effect of Contingency Management (CM) combined with Cognitive-Behavioral Treatment (CBT) on certain in-treatment behaviors.
Incentives for smoking cessation - Notley, C - 2019Results of a year‐long incentives‐based worksite smoking‐cessation program. Addictive Behaviors 1993;18(4):455‐64. Glasgow RE, Hollis JF, Ary DV, Lando HA.
7.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/24793364/
Prize contingency management for smoking cessation - PubMedResults: Prize CM resulted in significant reductions in cigarette smoking relative to SC. These reductions were not apparent at follow-up. We ...
Randomized Trial of Four Financial-Incentive Programs for ...Studies to better refine this reversion curve could lead to improved contingency management-based methods for guiding smoking cessation therapy [49] . ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security